UBS AM’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$861K Sell
574,107
-100,741
-15% -$128K ﹤0.01% 2389
2026
Q1
$769K Buy
674,848
+1,283
+0.2% +$1.58K ﹤0.01% 2430
2025
Q4
$849K Hold
673,565
﹤0.01% 2193
2025
Q3
$1.04M Sell
673,565
-453,911
-40% -$623K ﹤0.01% 1991
2025
Q2
$1.49M Buy
1,127,476
+345,842
+44% +$473K ﹤0.01% 2272
2025
Q1
$1.3M Buy
781,634
+28,254
+4% +$46.5K ﹤0.01% 2199
2024
Q4
$1.11M Buy
753,380
+148,322
+25% +$227K ﹤0.01% 2321
2024
Q3
$902K Sell
605,058
-149,104
-20% -$221K ﹤0.01% 2451
2024
Q2
$943K Buy
754,162
+352,973
+88% +$458K ﹤0.01% 2402
2024
Q1
$481K Hold
401,189
﹤0.01% 2300
2023
Q4
$606K Hold
401,189
﹤0.01% 2258
2023
Q3
$642K Sell
401,189
-39,093
-9% -$71.2K ﹤0.01% 2181
2023
Q2
$643K Hold
440,282
﹤0.01% 2224
2023
Q1
$643K Buy
440,282
+106,211
+32% +$137K ﹤0.01% 2224
2022
Q4
$418K Hold
334,071
﹤0.01% 2246
2022
Q3
$631K Sell
334,071
-116,125
-26% -$275K ﹤0.01% 2234
2022
Q2
$1.14M Sell
450,196
-14,389
-3% -$42K ﹤0.01% 1885
2022
Q1
$1.6M Buy
464,585
+4,366
+0.9% +$15.4K ﹤0.01% 1909
2021
Q4
$2.21M Buy
460,219
+29,127
+7% +$118K ﹤0.01% 1820
2021
Q3
$1.57M Buy
431,092
+4,577
+1% +$17K ﹤0.01% 1943
2021
Q2
$1.73M Buy
426,515
+12,456
+3% +$48.8K ﹤0.01% 1920
2021
Q1
$1.78M Sell
414,059
-112,264
-21% -$536K ﹤0.01% 1795
2020
Q4
$2.08M Buy
526,323
+92,528
+21% +$386K ﹤0.01% 1667
2020
Q3
$1.6M Buy
433,795
+49,921
+13% +$211K ﹤0.01% 1640
2020
Q2
$1.31M Buy
383,874
+129,527
+51% +$290K ﹤0.01% 1689
2020
Q1
$341K Buy
254,347
+16,565
+7% +$26K ﹤0.01% 2120
2019
Q4
$350K Sell
237,782
-15,917
-6% -$26.6K ﹤0.01% 2337
2019
Q3
$530K Buy
253,699
+38,708
+18% +$79.1K ﹤0.01% 2262
2019
Q2
$525K Sell
214,991
-60,655
-22% -$132K ﹤0.01% 2191
2019
Q1
$719K Sell
275,646
-24,943
-8% -$75.5K ﹤0.01% 1952
2018
Q4
$905K Hold
300,589
﹤0.01% 1794
2018
Q3
$1.04M Hold
300,589
﹤0.01% 1799
2018
Q2
$1.41M Sell
300,589
-16,845
-5% -$63.9K ﹤0.01% 1665
2018
Q1
$1.01M Buy
317,434
+39,900
+14% +$161K ﹤0.01% 1779
2017
Q4
$1.36M Buy
277,534
+40,626
+17% +$236K ﹤0.01% 1607
2017
Q3
$1.63M Buy
236,908
+12,240
+5% +$77.2K ﹤0.01% 1488
2017
Q2
$1.48M Buy
224,668
+17,541
+8% +$123K ﹤0.01% 1486
2017
Q1
$1.66M Buy
207,127
+36,153
+21% +$304K ﹤0.01% 1423
2016
Q4
$1.59M Sell
170,974
-78,903
-32% -$816K ﹤0.01% 1381
2016
Q3
$2.65M Buy
249,877
+1,400
+0.6% +$13.9K ﹤0.01% 1269
2016
Q2
$2.32M Buy
248,477
+13,699
+6% +$139K ﹤0.01% 1311
2016
Q1
$2.44M Sell
234,778
-35,904
-13% -$328K ﹤0.01% 1292
2015
Q4
$2.72M Buy
270,682
+4,300
+2% +$43.1K ﹤0.01% 1300
2015
Q3
$2.24M Buy
266,382
+94,838
+55% +$1.26M ﹤0.01% 1371
2015
Q2
$2.76M Buy
171,544
+49,149
+40% +$764K ﹤0.01% 1258
2015
Q1
$1.73M Buy
122,395
+18,900
+18% +$246K ﹤0.01% 1418
2014
Q4
$1.03M Buy
103,495
+4,900
+5% +$41.9K ﹤0.01% 1580
2014
Q3
$839K Buy
98,595
+1,400
+1% +$12.3K ﹤0.01% 1622
2014
Q2
$859K Hold
97,195
﹤0.01% 1629
2014
Q1
$906K Hold
97,195
﹤0.01% 1607
2013
Q4
$820K Buy
97,195
+3,800
+4% +$38.4K ﹤0.01% 1592
2013
Q3
$823K Buy
93,395
+39,000
+72% +$313K ﹤0.01% 1576
2013
Q2
$386K Buy
+54,395
New +$376K ﹤0.01% 1830

Other funds holding OPK

UBS AM's OPK Position: Q2 2026 in Review

UBS AM reduced its Opko Health (OPK) stake by 15% in Q2 2026, selling an estimated $128K and leaving 574,107 shares worth $861K. The position accounts for ﹤0.01% of the portfolio, ranked #2389.

UBS AM first reported a position in OPK in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.76M in Q2 2015. 223 funds tracked by Wall St. Rank hold OPK as of Q2 2026.

  • UBS AM held 574,107 shares of Opko Health worth $861K as of Q2 2026.
  • UBS AM sold 100,741 Opko Health shares in Q2 2026, an estimated $128K.
  • Opko Health made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2389 holding.
  • UBS AM first reported a position in Opko Health in Q2 2013 and has held it in 53 quarters since.
  • UBS AM's Opko Health position peaked at $2.76M in Q2 2015.
  • 223 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.